title: Development of measles vaccines in Japan.
abstract: Studies on measles vaccine development started in 1950s in Japan. After 3-year studies on development of further attenuated live measles vaccines by Japan Measles Vaccine Research Commission, two kinds of vaccines of different strains were licensed for optional use in 1971. In 1978, periodical immunization against measles was started using BIKEN CAM-70 vaccine, Takeda Schwarz-FF8 vaccine and Kitasato AIK-C vaccine. Combined measles and rubella vaccines (MR vaccine) were licensed in 2005. Periodical immunization with MR vaccines of BIKEN and Takeda Pharmaceutical Co. Ltd. to eliminate measles together with rubella from Japan by 2012 was started for children 1- and 6 (5-7)-year of age in 2006.
authors.affiliation: The Research Foundation for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan. s-ueda@mail.biken.or.jp
authors.forename: Shigeharu
authors.initials: S
authors.lastname: Ueda
mesh_terms: D006801:Humans; D007564:Japan; D008458:Measles Vaccine / Q000276:immunology*; D012411:Rubella Vaccine / Q000276:immunology; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000276:immunology; D017778:Vaccines, Combined / Q000276:immunology
chemical_list: D008458:Measles Vaccine; D012411:Rubella Vaccine; D014613:Vaccines, Attenuated; D017778:Vaccines, Combined